MSF Opposes Pfizer’s Pneumonia Vaccine Patent Application In India

LiveMint: Doctors Without Borders opposes Pfizer’s pneumonia vaccine patent in India
“Médecins Sans Frontières (MSF)/Doctors Without Borders, a Paris-based international humanitarian-aid non-governmental organization, on Friday said it has filed a ‘patent opposition’ in India to prevent U.S. pharmaceutical company Pfizer Inc. from getting a patent on the pneumococcal conjugate vaccine (PCV13), so more affordable versions can become available to developing countries and humanitarian organizations…” (Pila, 3/14).

Reuters: Médecins Sans Frontières files to block Pfizer patent on pneumonia vaccine in India
“…Some of the world’s poorest countries and medical charities such as Médecins Sans Frontières (MSF) depend on India’s robust pharmaceutical industry to make cheaper forms of drugs and vaccines developed by big Western pharmaceutical companies such as Pfizer. If India granted Pfizer a patent on its Prevnar 13 pneumonia vaccine, Indian firms would not be able to produce affordable versions of it for domestic use or exports, MSF said…” (Siddiqui, 3/11).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.